NEW YORK — The US Food and Drug Administration has issued warning letters to four direct-to-consumer health testing companies for selling unauthorized blood collection kits for HIV diagnosis.
The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback